In a report released yesterday, Joseph Thome from TD Cowen maintained a Buy rating on Prime Medicine, Inc. (PRME – Research Report). The ...

Cathie Wood's ARK Innovation ETF (ARKK) has surged to its highest trading level in more than two years this week, surpassing ...

Indaptus Therapeutics has evolved from more than a century of immunotherapy ... The product candidates are designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or ...

Canada ordered striking dock workers back to the ports of Vancouver, Prince Rupert and Montreal on Tuesday to clear out more ...

MRCLS had clinical responses with lete-celResults include six complete responses (6/64); twenty-one partial responses ...

ALT5 Prime is an electronic over-the-counter trading platform ... The Company is working on the separation of our biotech business that will become known as 'Alyea Therapeutics.' Forward Looking ...

LOS ALTOS, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive ...